Cytotoxic T Lymphocytes
P. Golstein,
P. Golstein
Centre d'Immunologie INSERM-CNRS de Marseille, Marseille, France
Search for more papers by this authorP. Golstein,
P. Golstein
Centre d'Immunologie INSERM-CNRS de Marseille, Marseille, France
Search for more papers by this authorFirst published: 15 January 2002
No abstract is available for this article.
Bibliography
- 1 A. Govaerts (1960) J. Immunol. 85, 516–522.
- 2 M. Poenie, R. Y. Tsien, and A.-M. Schmitt-Verhulst (1987) EMBO J. 6, 2223–2232.
- 3 A. Kupfer, G. Dennert, and S. J. Singer (1985) J. Mol. Cell. Immunol. 2, 37–49.
- 4 J. H. Russell, V. Masakovski, T. Rucinsky, and G. Phillips (1982) J. Immunol. 128, 2087–2094.
- 5 J. J. Cohen et al. (1985) Adv. Exp. Med. Biol. 184, 493–508.
- 6 J. F. R. Kerr, A. H. Wyllie, and A. R. Currie (1972) Br. J. Cancer 26, 239–257.
- 7 P. A. Henkart (1985) Annu. Rev. Immunol. 3, 31–58.
- 8 E. R. Podack (1985) Immunol. Today 6, 21–27.
- 9 D. Kägi et al. (1994) Nature 369, 31–37.
- 10 J.-F. Brunet et al. (1986) Nature 322, 268–271.
- 11 C. G. Lobe et al. (1986) Science 232, 858–861.
- 12 D. Masson and J. Tschopp (1987) Cell 49, 679–685.
- 13 H. K. Gershenfeld and I. L. Weissman (1986) Science 232, 854–858.
- 14 J. W. Heusel et al. (1994) Cell 76, 977–987.
- 15 C. J. Froelich et al. (1996) J. Biol. Chem. 271, 29073–29079.
- 16 D. A. Jans et al. (1996) J. Biol. Chem. 271, 30781–30789.
- 17 L. Shi et al. (1997) J Exp. Med. 185, 855–866.
- 18 A. J. Darmon, D. W. Nicholson, and R. C. Bleackley (1995) Nature 377, 446–448.
- 19 A. Sarin et al. (1997) Immunity 6, 209–215.
- 20 E. Rouvier, M.-F. Luciani, and P. Golstein (1993) J. exp. Med. 177, 195–200.
- 21 S. Yonehara, A. Ishii, and M. Yonehara (1989) J. Exp. Med. 169, 1747–1756.
- 22 B. C. Trauth et al. (1989) Science 245, 301–305.
- 23 T. Suda, T. Takahashi, P. Golstein, and S. Nagata (1993) Cell 75, 1169–1178.
- 24 J. H. Russell, B. Rush, C. Weaver, and R. Wang (1993) Proc. Nat. Acad. Sci. USA 90, 4409–4413.
- 25 D. Bellgrau et al. (1995) Nature 377, 630–632.
- 26 T. S. Griffith et al. (1995) Science 270, 1189–1192.
- 27 L. E. French and J. Tschopp (1997) Nat. Med. 3, 387–388.
- 28 T. Suda et al. (1995) J. Immunol. 154, 3806–3813.
- 29 F. Ramsdell et al. (1994) Internat. Immunol. 6, 1545–1553.
- 30 L. L. Carter and R. W. Dutton (1995) J. Immunol. 155, 1028–1031.
- 31 A. Anel et al. (1994) Eur. J. Immunol. 24, 2469–2476.
- 32 A. Anel et al. (1995) Eur. J. Immunol. 25, 3381–3387.
- 33 F. Vignaux et al. (1995) J. Exp. Med. 181, 781–786.
- 34 M.-F. Luciani and P. Golstein (1994) Roy. Soc. Phil. Trans. B 345, 303–309.
- 35 N. Itoh and S. Nagata (1993) J. Biol. Chem. 268, 10932–10937.
- 36 M. P. Boldin et al. (1995) J. Biol. Chem. 270, 387–391.
- 37 M. P. Boldin et al. (1995) J. Biol. Chem. 270, 7795–7798.
- 38 A. M. Chinnaiyan, K. O'Rourke, M. Tewari, and V. M. Dixit (1995) Cell 81, 505–512.
- 39 M. P. Boldin, T. M. Goncharov, Y. V. Goltsev, and D. Wallach (1996) Cell 85, 803–815.
- 40 M. Muzio et al. (1996) Cell 85, 817–827.
- 41 D. Kägi et al. (1994) Science 265, 528–530.
- 42 B. Lowin, M. Hahne, C. Mattmann, and J. Tschopp (1994) Nature 370, 650–652.
- 43 H. Kojima et al. (1994) Immunity 1, 357–364.
- 44 C. M. Walsh et al. (1994) Proc. Natl. Acad. Sci. USA 91, 10854–10858.
- 45 M. T. Esser, B. Krishnamurthy, and V. L. Braciale (1996) J. Exp. Med. 183, 1697–1706.
Suggestions for Further Reading
- G. Berke (1994). The binding and lysis of target cells by cytotoxic lymphocytes: Molecular and cellular aspects. Annu. Rev. Immunol. 12, 735–773.
- P. A. Henkart (1994). Lymphocyte-mediated cytotoxicity: two pathways and multiple effector molecules. Immunity 1, 343–346.
- S. Nagata and P. Golstein (1995). The Fas death factor. Science 267, 1449–1456.
- M. E. Peter, F. C. Kischkel, S. Hellbardt, A. M. Chinnaiyan, P. H. Krammer, and V. M. Dixit (1996). CD95(APO-1/Fas)-associating signalling proteins. Cell Death Differ. 3, 161–170.
